股票/基金 实时行情 股吧

简称:上海莱士 代码:002252


会计年度:2021-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计4,287,726,749.672,065,434,903.262,222,291,846.4151.83
其他(补充)3,007,725.682,498,905.00508,820.6816.92
血液制品生产及销售4,284,719,023.992,062,935,998.262,221,783,025.7351.85

会计年度:2021-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,755,724,588.09751,591,371.151,004,133,216.9457.19
其他(补充)542,668.25128,576.02414,092.2376.31
血液制品生产及销售1,755,181,919.84751,462,795.131,003,719,124.7157.19

会计年度:2020-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计2,761,682,036.391,050,123,130.861,711,558,905.5361.98
其他(补充)994,918.6977,804.00917,114.6992.18
血液制品生产及销售2,760,687,117.701,050,045,326.861,710,641,790.8461.96

会计年度:2020-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,309,311,248.48446,890,122.01862,421,126.4765.87
其他(补充)171,366.59------
血液制品生产及销售1,309,139,881.89446,890,122.01862,249,759.8865.86

会计年度:2019-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计2,584,983,982.36926,632,975.881,658,351,006.4864.15
其他(补充)234,765.09------
血液制品生产及销售2,584,749,217.27926,632,975.881,658,116,241.3964.15

    1/6 转到